Table 5.

Achievement of guideline-recommended goals for secondary prevention of CVD among participants with any self-reported CVD at baseline

VariablesHispanic n = 138Non-Hispanic Caucasian n = 507Non-Hispanic African American n = 627
n (%)n (%)Pn (%)P
Not current smoker132 (96)454 (90)0.03488 (78)<0.01
BP <130/80 mmHG55 (40)316 (62)<0.01244 (39)0.84
LDL ≤100101 (73)361 (71)0.65352 (56)<0.01
Physical activity 30 min/day, at least 5 d/wk51 (39)257 (53)<0.01259 (44)0.23
BMI <25 kg/m213 (9)74 (15)0.1276 (12)0.37
Waist circumference: men <40 in, women <35 in47 (35)154 (31)0.35138 (22)<0.01
Hg A1C <7%54 (39)313 (62)<0.01333 (53)<0.01
Aspirin use66 (48)343 (68)<0.01363 (58)0.03
RAS blocker use100 (73)397 (79)0.13479 (77)0.30
β-blocker use104 (76)346 (69)0.11452 (73)0.40
  • BMI, body mass index; Hg, hemoglobin; RAS, renin-angiotensin system.